Peter C. Richardson - EVP, Research and Development and Chief Medical Officer at Antares Pharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Research and Development and Chief Medical Officer
Stock Symbol
ATRS
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Peter C. Richardson since 12/22/2023

Holdings reported by Peter C. Richardson for Antares Pharma, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $5.60 May 24, 2022 Direct
Stock Option (right to buy) 0 May 24, 2022 Direct Common Stock

Transactions reported by Peter C. Richardson for Antares Pharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.